Advertisement

Latest News

REMIX: Early CSU Symptom Improvement Observed with Remibrutinib Therapy

36 minutes ago

These data from REMIX-1 and 2 suggest remibrutinib, in those with chronic spontaneous urticaria (CSU), can lead to fast, early symptom control.

AI-Enhanced ECGs Detect Early COPD, With Monica Kraft, MD

1 hour ago

Deep learning applied to routine ECGs identifies subtle cardiac signals linked to early COPD, potentially enabling earlier diagnosis and intervention.

VELA: Phase 3 Data Suggest Sonelokimab Effective for HS, With Alexa Kimball, MD, MPH

1 hour ago

This interview highlights phase 3 findings on sonelokimab for individuals with hidradenitis suppurativa (HS).

How Rewriting Race-Based GFR Equations Changed Kidney Transplant Access, With Pranav Garimella, MBBS, MPH

2 hours ago

Garimella discusses the history, clinical impact, and rationale for removing race-based GFR from clinical decision-making.

Single-Day GH001 Produces Rapid Remission in TRD, With Michael E. Thase, MD

3 hours ago

Inhaled GH001 achieved 57.5% remission by day 8 in TRD with a large effect size vs placebo; Thase discusses interpretation, unblinding, and phase 3 implications.

Advertisement
Advertisement